Skip to main content

Duke Urologic Assembly

UPDATE March 27, 2020 3:00 PM EST

The Planning Committee, led by Andrew J. Armstrong, MD, Michael N. Ferrandino, MD, Glenn M. Preminger, MD, in collaboration with the Duke Office of Continuing Medical Education has made the difficult, but necessary decision to cancel the 2020 DUA  to support efforts to contain and mitigate against threats posed by the coronavirus outbreak.  We wish to sincerely thank you for your patience and understanding as we evaluated postponement and cancellation options.  In response to these unprecedented circumstances, our leadership is adjusting the cancellation policy for this event.  Please also allow us time to process full registration fee refunds for the registrants.  Information for exhibitors and sponsors will be forthcoming.

 

UPDATE March 16, 2020 3:00 PM EST

CDC Guidance as of 3/15/2020

Large events and mass gatherings can contribute to the spread of COVID-19 in the United States via travelers who attend these events and introduce the virus to new communities. 

Therefore, CDC, in accordance with its guidance for large events and mass gatherings, recommends that for the next 8 weeks, organizers (whether groups or individuals) cancel or postpone in-person events that consist of 50 people or more throughout the United States.

UPDATE March 11, 2020 5:30 PM EST

Under the guidance of Duke University and Duke Health, the Planning Committee has made the difficult, but necessary decision to postpone the 2020 Leading Edge Urology Symposium to support efforts to contain and mitigate against threats posed by the coronavirus outbreak. We are currently investigating options to hold the meeting later this fall at the same venue.  Postponing the symposium is aimed at removing any additional risk posed to clinicians who would be needed to manage patients should the situation with coronavirus become more serious. The health, safety, and well-being of our attendees, staff, exhibitors, and faculty is of paramount importance. We will announce the dates and location of the rescheduled 2020 Leading Edge Urology Symposium as soon as they are confirmed. All currently registered attendees, exhibitors, and faculty will receive more information via e-mail in the coming days.

2020 LEADING EDGE UROLOGY: 52nd Duke Urologic Assembly & Urologic Cancer Symposium


Omni Hilton Head Ocenfront Hotel

 MARCH 26 - 29, 2020  

    

     Omni Hilton Head Oceanfront Resort

     Hilton Head, SC


 

2020 Duke Urologic Assembly & Urologic Cancer Symposium AGENDA

COURSE DESCRIPTION

Join an outstanding roster of national urologists, oncologists, and radiologists participating in a comprehensive scientific program that encompasses leading edge updates on the most effective and efficient diagnoses and treatments in the sub-specialties of urology. 

The rapid evolution of knowledge coupled with an unprecedented release of practice changing clinical trials require an ongoing review to ensure accurate diagnosis and disease management options by all levels of the urologic community.

Healthcare professionals attending this symposium will be engaged through interactive talks, supplemented with video surgical presentations, interactive case presentations, and panel discussions on the latest evidence-based clinical approaches to managing a wide range of urologic conditions.

TARGET AUDIENCE

Addressing current issues and technologies for the diagnoses and treatments in the subspecialties of urology and urologic oncology, this educational conference will meet the continuing educational needs,  enhance knowledge, skills and improve patient care by Urologists, Oncologists, Physician Assistants, Nurse Practitioners, Nurses, Residents and other allied health medical staff.

LEARNING OBJECTIVES

After attending this program, participants should be able to:
•Apply effective and efficient diagnosis and treatments in the sub-specialties of urology and urologic oncology
•Analyze new technologies and therapies to provide the utmost, least invasive care to patients
•Evaluate and outline management options for the various urologic conditions
•Choose appropriate patients for minimally invasive surgical approaches
•Distinguish various surgical approaches and compare their effectiveness and safety profiles
•Develop collaboration between urologists, genitourinary oncologists, and radiation oncologists for patient care from diagnosis to management

ACCREDITATION

 

    In support of improving patient care, the Duke University Health System Department of Clinical Education  and Professional Development is accredited by the Accreditation Council for Continuing Medical  Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses  Credentialing Center (ANCC) to provide continuing education for the health care team.

CREDIT DESIGNATION

     

Physician: 
Duke University Health System Department of Clinical Education and Professional Development designates this live activity for a maximum of 22.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Nurse CE:
Duke University Health System Department of Clinical Education and Professional  Development designates this activity for up to 22.5 credit hours for nurses. Nurses should claim only credit commensurate with the extent of their participation in this activity.
 

 

 


FUTURE CONFERENCE DATES:

LEADING EDGE UROLOGY: 53rd Duke Urologic Assembly and Urologic Cancer Symposium
April 8 - April 11, 2021

Being held at Disney's GRAND FLORIDIAN